Surender Kharbanda - Jan 11, 2022 Form 3 Insider Report for Hillstream BioPharma Inc. (HILS)

Role
10%+ Owner
Signature
/s/ Surender Kharbanda
Stock symbol
HILS
Transactions as of
Jan 11, 2022
Transactions value $
$0
Form type
3
Date filed
1/11/2022, 08:53 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HILS Common stock 721K Jan 11, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HILS Options (right to purchase) Jan 11, 2022 Common stock 946 $7.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Registrant issued the Reporting Person the options on January 1, 2021. The options vested and became exercisable immediately upon grant.